cbd in dental

CBD in Dentistry – Can Cannabis Cure Cavities?

Publié le 28 Avr 2015

Currently, the majority of research in medical marijuana focuses exclusively on analyzing its effectiveness in treating various ailments of the human body. Dental marijuana research has not been extensively investigated, and hallmark features critical to heal dentition with this medicinal drug are vastly unknown. This systematic research review aims to 1) identify various molecular caries (cavities) mechanisms and 2) determine future prospects of cannaboid research in dentistry.

Dental caries (rottenness) has been a somewhat intangible quality to measure, and attempts at eliminating it from dentistry have generally failed due to its intrinsic complexity. Dentistry pervades many aspects of our history and culture. During the mid 16 th century of the Renaissance period, dental patients sought to use herbs such as rosemary charcoal to not only maintain proper oral hygiene, but to alleviate painful tooth decay that many can empathize with to this day. Sage shrubs were also used to become an effective “teeth-whitening strip”, often cooked tediously and compounded to activate the “whitening” ingredients. Dentistry has evolved our entire life for hundreds of centuries, yet modern studies of dentistry have neglected to enhance or advance the same natural remedies used centuries ago to date. To this end, with the emerging knowledge of medicinal marijuana benefits, more specifically cannabidiol active ingredients (CBD), there has been a profound transition to identify the benefits of this drug at a clinical level. Many paste products focusing on hemp and marijuana plant driven ingredients have marketed this plant in hopes of penetrating the 12 billion dollar market share of the toothpaste industry. Yet the influences of various commercially available toothpaste products are fairly similar, with fluoride as their primary active ingredient in varying quantities. Generally, these pastes contain limited ingredients; resulting in limited data collection to determine the best paste that would effectively combat tooth decay. Furthermore, utilizing a wide range of focus group patients to evaluate caries, or recruiting study participants who are willing to use placebo paste, or ineffective paste in an effort to prevent caries, is often a violation of IRB research protocol. These two factors can limit the breadth and scope of most dental studies, as it is often difficult to control the basic parameters of the oral cavity unique to each participant.

Caries at Molecular Level

There is much dental literature that shows molecularly identified causes of dental caries (cavities). Various pathways that regulate protein metabolism, glucose regulation, and transaminase reactions have been shown clinically to cause caries. These unique pathways allow for colonization of biofilms in the oral mucosa and produce a harmful acidic environment that causes demineralization of dentition, and ultimately infection and caries. Traditionally, dental decay can more or less be detected with radiographs and clinical examination of the dentition. Various descriptions such as E1 (Enamel), E2, D1 (Dentin), D2, D3 lesions are often diagnosed by the dentist and assessed for treatment.

Of note, bacteria such as Streptococcus mutans and Lactobacillus are two of the most common bacterial organisms that are subject to scrutiny due to their prevalence in causing caries. 1 Furthermore, pH and availability of glycoproteins have the most salient influence on the composition and biochemical activities of biofilms. In other words, the more basic or alkaline the oral cavity, the less probability that bacteria will colonize and cause decay. Research in prevention and treatment of dental caries at the molecular level has become seemingly more important to the medical arena in recent years. 1, 2

STAMP tool

A novel method that is currently at a pilot stage is the STAMP tool, which is an acronym for “specifically targeted antimicrobial peptides.”

“The toothy tool comes from scientists including Wenyuan Shi, PhD, of the School of Dentistry at the University of California, Los Angeles (UCLA). They call their tool “STAMP” (specifically targeted antimicrobial peptides). Basically, STAMP is a tiny protein that knocks out a cavity-causing bacterium without harming healthy bacteria,” Dr. Shi explains in a news release from the National Institute of Dental and Craniofacial Research, one of the study’s sponsors.

“The good bacteria are mixed in with the bad ones,” Shi says.

Current treatments “simply clear everything away,” Shi says. “That can be a problem because we have data to show that the pathogens [the bad bacteria] grow back first.” More on this can be found here

Signal Recognition Particle Pathway

Much like other organisms that use various protein pathways to survive, one of the most prevalent mechanisms is the use of a signal recognition particle pathway (SRP) to deliver a protective protein layer to cellular membrane receptors in harsh acidic environmental conditions. 1, 7 Research has shown that a lack of infusion of protein to the membrane will yield a weakened cellular membrane that is prone to attack by bacterial defense mechanism in saliva such as beta-defensin-.1 1 S. mutans uses this pathway for growth by protein recognition and delivery to membrane. Recent research however has shown thatS.mutans can use an alternative form of this pathway for growth and adherence to tissue. 3 Two other molecular genes called YidC1 and YidC2 has been suggested to act as an alternate route for protein delivery to the membrane in the absence of the SRP pathway. 3

Aspartate Amino Transferase

Delivery of protein by the SRP pathway (or other alternative pathways) has lead researchers to investigatehow the organism can metabolize protein within the cell. Investigators have identified much bacterial protein activity on the pellicle layer of teeth, which has been a causative agent in caries. Two of the most ubiquitous protein processes that many bacterial organisms utilize is the alanine amino transferase (ALT), and the aspartate amino transferase (AST) pathways. 7 Both amino transferases catalyzes the transfer of an amino group from alanine or aspartate to α-ketoglutarate, which in turn produce either pyruvate and glutamate or oxalacetate and glutamate respectfully. 3 This process allows bacterial organisms to use various glycoprotiens (such as proline) within the enamel surface for bacterial adhesion and growth. 3 Studies have shown that the AST and ALT pathways significantly increase with patients suffering from periodontal disease and high-risk caries. This implies a strong correlation with ALT and AST pathways in dental caries, though much analysis is required for recognition. 3

Glucose Transport

Glucose transport to various parts of cellular tissue is a common pathway for many organisms to function properly. 6, 7 Many bacteria use a specific glucose transport system to regulate their metabolism and allow for the survival of cohort species. Research has investigated that oral bacteria (S. mutan, S sanguis) generally use a Phosphoenolpyruvate (PEP-dependent) mechanism for glucose transport. 4, 5 Through various target receptors and secondary messengers, the main mechanism of action allows for phosphorylation of a glucose molecule at carbon 6, which has been shown to cause resistance to fluoride. 5, 6 Research has also shown that this pathway has inhibitory effects on glycolysis by blocking enolase activity, thus allowing the bacteria to prevent excessive uptake of glucose while in the anabolic process of growth. 4, 5

These pathways are just a select few that have given dental clinicians artillery of information to combat dental decay. The focus on the mechanism of action (protein metabolism, glucose regulation, and transaminase reactions) of oral bacteria can be one of the most promising areas of knowledge to prevent dental caries. There may be a growing need for many clinicians is to look further into medical marijuana effects in dental caries, more specifically enabling biofilm degradation as well as preventive treatment of caries with antibacterial properties of CBD. The technology and science behind this type of dental research has been documented for decades, but lacks the necessary focus required to determine CBD effects in dentistry. I believe as the general public becomes more aware of the beneficial ingredients of medical marijuana in quality treatment and care, it will soon find its way to become a multi-billion dollar industry in dentistry.

Cannabidiol (CBD) and Dentistry
With the emerging indications of the effectiveness of CBD in medical therapy, dentists should begin to seriously consider the vast implications of medical marijuana as part of their dental therapy regiment. And while ignoring the stigma and taboo that marijuana often faces in society, progressive clinicians and dentists should recognize CBD as a powerful treatment modality. A simple google search on CBD and its benefits is readily available and such benefits are generally recognized by clinicians. Below is a chart adopted from that gives insight to the powerful affects of CBG, CBGA and CBCA. Note that antibacterial and anti-inflammatory ingredients are one of the most salient qualities needed in dentistry.

Cannabis Products

Cannabis products created by companies such as Axim Biotech are paving the way to fight dental decay with CBD. Cannabigerol, the active ingredient in Axim’s dental products, has shown to have anti-inflammatory properties, which are ideal in periodontal disease and gum sensitivity. This is a tantamount milestone in the world of dentistry. Much of the anti-inflammatory agents used currently are chlorohexidene irrigation rinses, which often tastes bitter and can leave a slight tooth discoloration with continual use. Axim is also engaged in creating a type of Canagum, which can basically allow for cannabinoids to be secreted into saliva, thus preventing biofilm attachment.

Another company, Cannaderm has a hemp infused toothpaste that is readily able to re-mineralize enamel and decrease tooth sensitivity.

The future of dentistry

Pilot clinical trials with CBD at a molecular level should be evaluated with the most common types of bacteria that cause tooth decay. (S. mutans, and Lactobacillis) Even a simple research experiment, where injections of CBD strains are assessed to determine colony forming units on a blood agar dish with S. mutans and Lactobacillis would be a promising attempt to develop an advance in this area. Dental research with CBD is far from over, but a handful of companies have demonstrated its potential value. In future work, clincians should seek to perform large-scale comparisons between CBD toothpaste vs regular toothpaste, and corresponding dental composite fillings treated with CBD infused composite glass ionomer products. The possibilities are truly endless.

This collective approach will allow us to combat tooth decay both comprehensively and vigorously. Future studies will emulate ideas conveyed in this paper and may realistically require more than 100 clinical trials in order to achieve profound evidence based clinical power, nevertheless, it is something that should be sought and meticulously scrutinized by dental clinical research.

CBD in Dentistry – Can Cannabis Cure Cavities?

Cannabis For Your Mouth: R&D, Patents, And Your Next Visit To The Dentist

The United States’ cannabidiol (CBD) market may soon see a boon in oral care products, premium brands may seek patents with no certainties they will be enforced. + Ways to survive the dentist.

Cannabis and oral care are a complementary combination making more and more sense to researchers and . [+] scientists. | CBD drops, CBD Capsules, CBD oils can all be used for oral care.

Oral diseases are the most common non communicable diseases across the globe according to the World Health Organization, which also estimates severe periodontal disease to be the 11th most common disease worldwide. And severe tooth loss and edentulism (tooth loss) is one of the leading ten causes of Years Lived with Disability (YLD) in some high-income countries.

At the same time, cannabidiol has taken the United States’ health, beauty, and wellness products industry by storm. In a survey of 2,000 U.S. consumers, 1,500 reported using a CBD product within the last three months.

With CBD’s well-cited effects treating inflammation and fighting bacteria, it makes sense that oral health and CBD should grow closer and closer together in the form of consumer products.

After all, at-home recipes for CBD mouthwash, CBD charcoal oil, and other oral health solutions already dwell in Google databases, signaling an undeniable demand for CBD oral health products. Or at least a really determined curiosity. `

Microdosing Psychedelics Is Trendy, But Does It Work? Here’s What Science Says

Even The Bookies Want The Election To Be Over—And The Betting To Stop

Could President Joe Biden Legalize Marijuana? Not Really—And The Marijuana Industry Doesn’t Want Him To Try.

A few cannabis, biotech, and pharmaceutical companies have been developing and testing cannabis-derived oral care solutions from the beginning, aiming to get them on the shelves of drug stores and health food stores as quickly as possible.

Cannabinoid research and product development company, AXIM® Biotechnologies, Inc. (OTC: AXIM), has a history of developing cannabis-derived oral health products through extensive research. The company recently partnered with Impression Healthcare to supply its CBD toothpaste and mouthwash for a clinical periodontitis treatment trial.

They’re looking to test the effectiveness of CBD in treating periodontitis, with trials to be performed at Swinburne University of Technology in Melbourne, Australia. The teams are using a patented formula developed by Axim to maximize the presence of CBD in the oral cavity during brushing.

“CBD is a powerful antibiotic and anti-inflammatory, so we have found it has great benefits in relation to oral care after years of offering our patented CBD-based chewing gum,” Axim CEO John W. Huemoeller II related in a written interview. “The inclusion of CBD for anti-inflammatory and antibiotic is intended to aid reduction in gum swelling while helping to eliminate infection-causing bacteria.”

The end game is a new line of CBD oral hygiene products, including toothpaste and mouthwash, for the treatment of symptoms associated with gum disease. Huemoeller cites consumer preferences as key to his company’s commitment to develop these products. “They [consumers] are eager to have wider access to safely regulated CBD for their various needs,” he believes.” Consumer buying trends will heavily shape the currently vast CBD industry as companies see buying trends lean to one type of product or another.”

Advances in cannabis-derived oral health research and development paired with this consumer power will only further an already active wave of changing sentiment about cannabis in America. “As CBD comes to light as a health supplement with a range of potential treatments, the FDA is already feeling the pressure from the CBD industry and its consumers to allow the non-psychoactive compound to be added into foods and beverages,” Huemoeller said.

Patents and customized cannabis

If the budding CBD oral health care product market grows to resemble that of click-to-buy CBD bath bombs one, the same formula with different labels will sit side-by-side on the shelf of a CVS. As these generic cannabis oral care products enter the market, unique characteristics, predictable and precise effects, and strong efficacy will be needed to separate premium brands from all the others.

Once the right mix of process and ingredients is realized, these “formulations” will need protection and preservation.

This is because the future of weed is in formulations, according to this great reference piece on customized cannabis by Madison Margolin of Rolling Stone. The direction of cannabis consumer market preferences is towards still about the experience—but ones with precisely anticipated effects. “Consumers — especially novice consumers — more and more will veer toward a manufactured cannabis oil, edibles, pills, or tinctures, designed by scientists to target the consumer’s specific needs,” she predicted.

“The basis of these products are specially curated chemical concoctions, donning specific ratios of cannabinoids (like THC and CBD) and terpenes, aromatic compounds that provide a distinct character to each of marijuana’s varied psychoactive effects,” Margolin explains.

All that research and development needs protecting.

That’s why companies like Axim are looking at the structure of CBD, and replicating it in a lab to make a completely new compound that retains 99% the same effectiveness as the plant or more. These novel compounds of synthetic CBD can be patented in the same way as any chemical product. But with a few caveats.

The United States Patent and Trademark Office (USPTO) has been issuing cannabis-related patents since 1942, but the process and criteria still aren’t clear and consistent according to experts. Differences between federal and state cannabis laws and lack of consensus in accommodating them have caused confusion for lawyers and cannabis companies on precisely how to approach patents and trademarks.

“This is not a black and white issue,” said Ryan S. Osterweil, an attorney with Day Pitney LLP, a Connecticut based law firm, reports Cannabis Wire.

First, to get a patent, the invention must be novel and cannot already exist in nature. So that’s a big hurdle. With 80 years of prohibition, there is a massive lack of prior art and documentation for cannabis, a key criteria in patent application. And lastly, patent law is exclusively federal, and cannabis is still a Schedule 1 drug.

When you have a patent, it’s up to you to monitor it. Axim takes their patent enforcement seriously. “Anyone who infringes on our patents will receive notification letters,” Huemoeller said. “We will evaluate the cost of pursuing legal action and take the next steps from there. If any company generates income from our patents, we will have the ability to pursue them.”

While worthy cannabis patents are being rightfully earned, they come with no assurance they’ll be enforced by authorities. William J. McNichol, Jr., Adjunct Professor at Rutgers University School of Law, predicted that “the USPTO’s willingness to grant cannabis patents is unlikely to be matched by a willingness of the Federal Courts to enforce cannabis patents.”

Patents are valuable, regardless, because those who play by the rules will license them. “The good (big) players will license our patents, so they will become a proven revenue source for us,” Huemoeller told me.

Cannabis and the dentist

So where’s all this leave you until these premium new products hit the market? And next trip to the dentist’s office, how can cannabis help you with that?

It can do so by applying cannabis to do some of the things it’s already proven effective for. CBD can help reduce anxiety before a dental procedure, for example.

“A dose earlier in the day or even the night before can be taken if anxiety’s already struck,” advises Dr. Jared Helfant, who practices dentistry in Broward County, Florida, in an interview with Merry Jane writer A.J. Herrington. His dose recommendation is 1-1.5 milligrams of CBD per 10 pounds of body weight. “CBD taken [an hour] before a dental procedure, and again as anesthesia wears off, will also help prevent or lessen the associated pain,” he surmised.

For post-surgery relief, a sterile pad dipped in CBD oil can be used to contain the wounded area after a tooth extraction, and works as an analgesic. “The same applies when sensitive gums are sore and need to recover after the periodic deep cleaning performed by a professional,” according to Royal Queen Seeds. “In addition to the analgesic effect, CBD helps keep the area free of bacteria.”

Be stealthy in your “office visit” use of CBD if you choose that route. Some web surfing dentists have been trained to size-up patients who’ve smoked a hemp cigarette outside.

An article from DentistryIQ advises dentists on how to “recognize the signs” of a patient who’s used cannabis prior to their procedure. “These signs and symptoms may include the following: euphoria, hyperactivity, tachycardia, paranoia, delusions, and hallucinations,” the article reads. It then continues, “Other research has noted that “[d]ental treatment on patients intoxicated on cannabis can result in the patient experiencing acute anxiety, dysphoria and psychotic-like paranoiac thoughts.”

Some signs are easier to recognize.

My recent recent office visit wasn’t awkwardly surreptitiousness or tainted by hallucinations at all. just softened by a whole lot more tolerance for pain. Thanks for the CBD vape pen, Select CBD, I still had one left over from last year’s Emmys bags.

Disclosure: I have no financial interest or positions in the aforementioned companies. This information is for educational purposes and does not constitute financial and/or legal advice. But Select CBD did hook me up with a great free vape pen.

The United States’ cannabidiol (CBD) market may soon see a boon in oral care products, premium brands may seek patents with no certainties they will be enforced. + Ways to survive the dentist.